Loading
NM
Nova Mentis Life Science Corp. Stock: price and insider trades · Canada
Nova Mentis Life Science Corp.: what insiders have been doing
We have very little insider data for Nova Mentis Life Science Corp. so far: the most recent filing dates from 25 October 2024. With so few records, no pattern can be drawn yet. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
9
Thresholds
n/a
Buy Volume
€1,700
1 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 25 October 2024
Declarations9 total
Common SharesTSXSEDI:4393245
4,433,000 sharesCommon SharesTSXSEDI:4350385
4,025,000 sharesCommon SharesTSXSEDI:4350386
1,437,000 sharesCommon SharesTSXSEDI:4288775
69,375 sharesCommon SharesTSXSEDI:4288770
700,000 sharesCommon SharesTSXSEDI:4259938
Common SharesTSXSEDI:4247963
100,000 sharesCommon SharesTSXSEDI:4242832
100,000 shares@ CA$0.025100.0% of flowCommon SharesTSXSEDI:4225159
Canonical exit: 13 Mar 2024 (T+90)
9 of 9 declarations
About Nova Mentis Life Science Corp.
Nova Mentis Life Science Corp. is a biotechnology company focused on developing treatments for neurodevelopmental disorders. It is listed on the Toronto Stock Exchange.
